IQVIA Holdings Inc. (IQV)
What changed this quarter
- Risk factors — 1 removed · removed: Increasing focus on sustainability and othe…
- Free cash flow declined recently
What changed in recent SEC filings — factual, not a buy/sell recommendation.
Company overview
IQVIA. A clinical-trial CRO and medical-data-analytics company. It is a services company supporting pharma drug development and commercialization.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
IQVIA Holdings Inc. is classified under the Biotech & Health sector. See peers below.
IQVIA Holdings Inc. key financials
Based on SEC filings · latest quarter (TTM)
Tap a metric name to see its meaning in the glossary.
ETFs holding IQVIA Holdings Inc.
Per SEC N-PORT · 2026-03-31 · by weight · factual
IQV on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — valuation and growth vs the Biotech & Health average
Peers · Biotech & Health
IQV FAQ
What is IQVIA Holdings Inc. (IQV)?
IQVIA. A clinical-trial CRO and medical-data-analytics company. It is a services company supporting pharma drug development and commercialization.
What sector is IQVIA Holdings Inc. in?
IQVIA Holdings Inc. is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
What are IQVIA Holdings Inc.'s key financials?
Based on the latest quarter (TTM) from SEC filings: Revenue growth (YoY) 7.3%, Operating margin 12.4%, Net margin 8.3%, ROE 20.9%, Debt-to-equity 1.58x. Definitions and interpretation are available on Stocklore.
Where can I analyze IQVIA Holdings Inc. (IQV) stock?
On Stocklore you can see IQV's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, 45-day delay), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.